These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
654 related articles for article (PubMed ID: 22464327)
1. The pan-ErbB negative regulator Lrig1 is an intestinal stem cell marker that functions as a tumor suppressor. Powell AE; Wang Y; Li Y; Poulin EJ; Means AL; Washington MK; Higginbotham JN; Juchheim A; Prasad N; Levy SE; Guo Y; Shyr Y; Aronow BJ; Haigis KM; Franklin JL; Coffey RJ Cell; 2012 Mar; 149(1):146-58. PubMed ID: 22464327 [TBL] [Abstract][Full Text] [Related]
2. LRIG1 is a triple threat: ERBB negative regulator, intestinal stem cell marker and tumour suppressor. Wang Y; Poulin EJ; Coffey RJ Br J Cancer; 2013 May; 108(9):1765-70. PubMed ID: 23558895 [TBL] [Abstract][Full Text] [Related]
3. Loss of Lrig1 leads to expansion of Brunner glands followed by duodenal adenomas with gastric metaplasia. Wang Y; Shi C; Lu Y; Poulin EJ; Franklin JL; Coffey RJ Am J Pathol; 2015 Apr; 185(4):1123-34. PubMed ID: 25794708 [TBL] [Abstract][Full Text] [Related]
7. Epithelium-derived Indian Hedgehog restricts stromal expression of ErbB family members that drive colonic tumor cell proliferation. Westendorp F; Karpus ON; Koelink PJ; Vermeulen JLM; Meisner S; Koster J; Büller NVJA; Wildenberg ME; Muncan V; van den Brink GR Oncogene; 2021 Mar; 40(9):1628-1643. PubMed ID: 33479497 [TBL] [Abstract][Full Text] [Related]
8. IL-17R-EGFR axis links wound healing to tumorigenesis in Lrig1 Chen X; Cai G; Liu C; Zhao J; Gu C; Wu L; Hamilton TA; Zhang CJ; Ko J; Zhu L; Qin J; Vidimos A; Koyfman S; Gastman BR; Jensen KB; Li X J Exp Med; 2019 Jan; 216(1):195-214. PubMed ID: 30578323 [TBL] [Abstract][Full Text] [Related]
9. Epigenetic loss of heterozygosity of Apc and an inflammation-associated mutational signature detected in Lrig1 Preston JL; Stiffler N BMC Cancer; 2020 Feb; 20(1):126. PubMed ID: 32059662 [TBL] [Abstract][Full Text] [Related]
11. LRIG1 is a gatekeeper to exit from quiescence in adult neural stem cells. Marqués-Torrejón MÁ; Williams CAC; Southgate B; Alfazema N; Clements MP; Garcia-Diaz C; Blin C; Arranz-Emparan N; Fraser J; Gammoh N; Parrinello S; Pollard SM Nat Commun; 2021 May; 12(1):2594. PubMed ID: 33972529 [TBL] [Abstract][Full Text] [Related]
12. Crypt stem cells as the cells-of-origin of intestinal cancer. Barker N; Ridgway RA; van Es JH; van de Wetering M; Begthel H; van den Born M; Danenberg E; Clarke AR; Sansom OJ; Clevers H Nature; 2009 Jan; 457(7229):608-11. PubMed ID: 19092804 [TBL] [Abstract][Full Text] [Related]
13. LRIG1-Mediated Inhibition of EGF Receptor Signaling Regulates Neural Precursor Cell Proliferation in the Neocortex. Jeong D; Lozano Casasbuenas D; Gengatharan A; Edwards K; Saghatelyan A; Kaplan DR; Miller FD; Yuzwa SA Cell Rep; 2020 Oct; 33(2):108257. PubMed ID: 33053360 [TBL] [Abstract][Full Text] [Related]
14. Wnt-reporter expression pattern in the mouse intestine during homeostasis. Davies PS; Dismuke AD; Powell AE; Carroll KH; Wong MH BMC Gastroenterol; 2008 Dec; 8():57. PubMed ID: 19055726 [TBL] [Abstract][Full Text] [Related]
15. LRIG1 Regulates Ontogeny of Smooth Muscle-Derived Subsets of Interstitial Cells of Cajal in Mice. Kondo J; Powell AE; Wang Y; Musser MA; Southard-Smith EM; Franklin JL; Coffey RJ Gastroenterology; 2015 Aug; 149(2):407-19.e8. PubMed ID: 25921371 [TBL] [Abstract][Full Text] [Related]
16. Leucine-rich repeat and immunoglobulin domain-containing protein-1 (Lrig1) negative regulatory action toward ErbB receptor tyrosine kinases is opposed by leucine-rich repeat and immunoglobulin domain-containing protein 3 (Lrig3). Rafidi H; Mercado F; Astudillo M; Fry WH; Saldana M; Carraway KL; Sweeney C J Biol Chem; 2013 Jul; 288(30):21593-605. PubMed ID: 23723069 [TBL] [Abstract][Full Text] [Related]
17. Identification of stem cells in small intestine and colon by marker gene Lgr5. Barker N; van Es JH; Kuipers J; Kujala P; van den Born M; Cozijnsen M; Haegebarth A; Korving J; Begthel H; Peters PJ; Clevers H Nature; 2007 Oct; 449(7165):1003-7. PubMed ID: 17934449 [TBL] [Abstract][Full Text] [Related]
18. Expression of LRIG1, a Negative Regulator of EGFR, Is Dynamically Altered during Different Stages of Gastric Carcinogenesis. Yu S; Yang M; Lim KM; Cho Y; Kim H; Lee K; Jeong SH; Coffey RJ; Goldenring JR; Nam KT Am J Pathol; 2018 Dec; 188(12):2912-2923. PubMed ID: 30248341 [TBL] [Abstract][Full Text] [Related]
19. Using a new Lrig1 reporter mouse to assess differences between two Lrig1 antibodies in the intestine. Poulin EJ; Powell AE; Wang Y; Li Y; Franklin JL; Coffey RJ Stem Cell Res; 2014 Nov; 13(3 Pt A):422-30. PubMed ID: 25460603 [TBL] [Abstract][Full Text] [Related]
20. Lrig1: a new master regulator of epithelial stem cells. Ordóñez-Morán P; Huelsken J EMBO J; 2012 May; 31(9):2064-6. PubMed ID: 22433838 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]